바이오마린제약(주)
US ˙ NasdaqGS ˙ US09061G1013

SecurityBMRN / BioMarin Pharmaceutical Inc.
InstitutionJefferies Group LLC
Latest Disclosed Ownership21,780 shares
Latest Disclosed Value $ 1,846,291
Jefferies Group LLC ownership in BMRN / BioMarin Pharmaceutical Inc.

On September 21, 2023 - Jefferies Group LLC filed a 13F-HR/A form disclosing ownership of 21,780 shares of BioMarin Pharmaceutical Inc. (US:BMRN) valued at $1,846,291 USD as of September 30, 2022. The entity filed a previous 13F-HR/A on September 21, 2023 disclosing 2,434 shares of BioMarin Pharmaceutical Inc.. This represents a change in shares of 794.82% during the quarter. The current value of the position is $1,236,451 USD.

Jefferies Group LLC has a history of taking positions in derivatives of the underlying security (BMRN) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

BMRN / BioMarin Pharmaceutical Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2023-09-21 2022-09-30 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 21,780 19,346 794.82 1,846 818.41 0.0154
2022-11-14 2022-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 21,780 17,610 1,846 0.0147
2023-09-21 2022-06-30 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 2,434 -6,316 -72.18 202 -70.18 0.0017
2022-08-15 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 4,170 -4,580 200 0.0016
2023-09-21 2022-03-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 8,750 960 12.32 675 -2.03 0.0042
2022-05-16 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 11,298 3,508 667 0.0039
2023-09-21 2021-12-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 7,790 -15,557 -66.63 688 -61.86 0.0040
2022-02-14 2021-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 7,790 -15,557 688 0.0037
2023-09-21 2021-09-30 13F/A-2 BIOMARIN PHARMACEUTICAL COM 09061G101 23,347 13,121 128.31 1,804 111.49 0.0132
2021-12-17 2021-09-30 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 23,347 13,121 1,804 0.0124
2021-11-15 2021-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 23,347 13,121 1,804 0.0116
2023-09-21 2021-06-30 13F/A-2 BIOMARIN PHARMACEUTICAL COM 09061G101 10,226 3,796 59.04 853 75.88 0.0054
2021-08-20 2021-06-30 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 10,226 3,796 853 0.0051
2021-08-16 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 10,226 3,796 853 0.0050
2023-09-21 2021-03-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 6,430 -17,663 -73.31 486 -77.04 0.0043
2021-05-14 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 6,430 -17,663 486 0.0043
2023-09-21 2020-12-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 24,093 23,917 13,589.20 2,113 16,146.15 0.0166
2021-02-16 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 24,093 23,917 2,113 0.0190
2020-11-13 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 176 -26,146 -99.33 13 -99.60 0.0001
2020-11-02 2020-06-30 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 26,322 17,889 212.13 3,247 355.40 0.0383
2020-08-14 2020-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 26,322 17,889 3,247 43,632.7144
2020-05-15 2020-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 8,433 -56,947 -87.10 713 -87.10 0.0089
2020-02-13 2019-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 65,380 -35,368 -35.11 5,528 -18.59 0.0428
2019-11-13 2019-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 100,748 82,426 449.87 6,790 332.76 0.0526
2019-08-14 2019-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 18,322 8,855 93.54 1,569 86.56 0.0114
2019-05-15 2019-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 9,467 -31,405 -76.84 841 -75.83 0.0069
2019-02-14 2018-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 40,872 -35,260 -46.31 3,480 -52.86 0.0284
2018-11-14 2018-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 76,132 6,159 8.80 7,383 12.02 0.0483
2018-08-14 2018-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 69,973 64,909 1,281.77 6,591 1,503.65 0.0369
2018-05-15 2018-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,064 -61,947 -92.44 411 -93.12 0.0022
2018-02-14 2017-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 67,011 63,988 2,116.71 5,975 2,026.33 0.0280
2017-11-14 2017-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 3,023 -16,732 -84.70 281 -84.34 0.0019
2017-08-14 2017-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 19,755 19,755 1,794 0.0120
2017-05-15 2017-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -7,192 -100.00 0 -100.00
2017-02-14 2016-12-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 7,192 1,271 21.47 596 8.76 0.0033
2017-02-14 2016-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 7,192 596
2016-11-14 2016-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,921 -20,073 -77.22 548 -72.90 0.0028
2016-08-12 2016-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 25,994 -5,297 -16.93 2,022 -21.66 0.0092
2016-05-11 2016-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 31,291 31,144 21,186.39 2,581 17,106.67 0.0149
2016-02-12 2015-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 147 -19,447 -99.25 15 -99.27 0.0001
2015-11-13 2015-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 19,594 -12,175 -38.32 2,064 -52.50 0.0118
2015-08-18 2015-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 31,769 13,114 70.30 4,345 86.96 0.0224
2015-05-18 2015-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 18,655 8,673 86.89 2,324 157.65 0.0130
2015-02-17 2014-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 9,982 -7,018 -41.28 902 -26.49 0.0053
2014-11-17 2014-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 17,000 -65,533 -79.40 1,227 -76.10 0.0084
2014-08-14 2014-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 82,533 -8,134 -8.97 5,134 -16.98 0.0434
2014-05-16 2014-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 90,667 89,282 6,446.35 6,184 6,275.26 0.0601
2014-02-18 2013-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,385 -17,981 -92.85 97 -93.06 0.0006
2013-11-18 2013-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 19,366 10,048 107.83 1,398 169.36 0.0137
2013-08-15 2013-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 9,318 9,318 519 0.0056
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-09-21 2022-06-30 13F/A BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-08-15 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 0 0 n/a n/a n/a
2023-09-21 2022-03-31 13F/A BIOMARIN PHARMACEUTICAL COM Call 40,000 3,084 n/a n/a n/a
2022-05-16 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 40,000 3,084 n/a n/a n/a
2021-12-17 2021-09-30 13F/A BIOMARIN PHARMACEUTICAL COM Call 0 0 n/a n/a n/a
2023-09-21 2021-09-30 13F/A BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-15 2021-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 0 0 n/a n/a n/a
2021-08-20 2021-06-30 13F/A BIOMARIN PHARMACEUTICAL COM Call 27,600 2,303 n/a n/a n/a
2023-09-21 2021-06-30 13F/A BIOMARIN PHARMACEUTICAL COM Call 27,600 0.00 2,303 10.46 n/a n/a n/a
2021-08-16 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 2,760,000 2,303 n/a n/a n/a
2023-09-21 2021-03-31 13F/A BIOMARIN PHARMACEUTICAL COM Call 27,600 -38.67 2,084 -47.19 n/a n/a n/a
2021-05-14 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 27,600 2,084 n/a n/a n/a
2023-09-21 2020-12-31 13F/A BIOMARIN PHARMACEUTICAL COM Call 45,000 363.92 3,946 434.69 n/a n/a n/a
2021-02-16 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 45,000 3,946 n/a n/a n/a
2020-11-13 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 9,700 -35.33 738 -60.11 n/a n/a n/a
2020-11-02 2020-06-30 13F/A BIOMARIN PHARMACEUTICAL COM Call 15,000 0.00 1,850 45.90 n/a n/a n/a
2020-08-14 2020-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 15,000 1,850 n/a n/a n/a
2020-05-15 2020-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 15,000 -85.07 1,268 -85.08 n/a n/a n/a
2020-02-13 2019-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 100,500 45.23 8,497 82.18 n/a n/a n/a
2019-11-13 2019-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 69,200 4,664 n/a n/a n/a
2019-08-14 2019-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-05-15 2019-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 34,300 -71.27 3,047 -70.03 n/a n/a n/a
2019-02-14 2018-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 119,400 752.86 10,167 648.67 n/a n/a n/a
2018-11-14 2018-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 14,000 268.42 1,358 279.33 n/a n/a n/a
2018-08-14 2018-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 3,800 52.00 358 76.35 n/a n/a n/a
2018-05-15 2018-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 2,500 203 n/a n/a n/a
2017-02-14 2016-12-31 13F/A BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2016-11-14 2016-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 26,900 2,489 n/a n/a n/a
2016-05-11 2016-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2016-02-12 2015-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 27,600 420.75 2,891 418.10 n/a n/a n/a
2015-11-13 2015-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 5,300 -87.56 558 -90.42 n/a n/a n/a
2015-08-18 2015-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 42,600 1,836.36 5,827 2,026.64 n/a n/a n/a
2015-05-18 2015-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 2,200 -98.11 274 -97.39 n/a n/a n/a
2015-02-17 2014-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 116,200 10,504 n/a n/a n/a
2014-11-17 2014-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2014-08-14 2014-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 23,900 -85.42 1,487 -87.43 n/a n/a n/a
2013-11-18 2013-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 163,900 11,829 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-09-21 2022-09-30 13F/A BIOMARIN PHARMACEUTICAL COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-11-14 2022-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 0 0 n/a n/a n/a
2023-09-21 2022-06-30 13F/A BIOMARIN PHARMACEUTICAL COM Put 10,000 829 n/a n/a n/a
2022-08-15 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 10,000 829 n/a n/a n/a
2023-09-21 2021-12-31 13F/A BIOMARIN PHARMACEUTICAL COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-12 2021-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 0 0 n/a n/a n/a
2021-12-17 2021-09-30 13F/A BIOMARIN PHARMACEUTICAL COM Put 31,500 2,435 n/a n/a n/a
2023-09-21 2021-09-30 13F/A BIOMARIN PHARMACEUTICAL COM Put 31,500 110.00 2,435 94.56 n/a n/a n/a
2021-11-15 2021-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 31,500 2,435 n/a n/a n/a
2021-08-20 2021-06-30 13F/A BIOMARIN PHARMACEUTICAL COM Put 15,000 1,252 n/a n/a n/a
2023-09-21 2021-06-30 13F/A BIOMARIN PHARMACEUTICAL COM Put 15,000 0.00 1,252 10.51 n/a n/a n/a
2021-08-16 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 1,500,000 1,252 n/a n/a n/a
2023-09-21 2021-03-31 13F/A BIOMARIN PHARMACEUTICAL COM Put 15,000 -39.52 1,133 -47.93 n/a n/a n/a
2021-05-14 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 15,000 1,133 n/a n/a n/a
2023-09-21 2020-12-31 13F/A BIOMARIN PHARMACEUTICAL COM Put 24,800 153.06 2,175 191.42 n/a n/a n/a
2021-02-16 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 24,800 2,175 n/a n/a n/a
2020-11-13 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 9,800 84.91 746 14.07 n/a n/a n/a
2020-11-02 2020-06-30 13F/A BIOMARIN PHARMACEUTICAL COM Put 5,300 0.00 654 45.98 n/a n/a n/a
2020-08-14 2020-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 5,300 654 n/a n/a n/a
2020-05-15 2020-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 5,300 448 n/a n/a n/a
2020-02-13 2019-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-11-13 2019-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 75,800 516.26 5,109 385.19 n/a n/a n/a
2019-08-14 2019-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 12,300 284.38 1,053 270.77 n/a n/a n/a
2019-05-15 2019-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 3,200 -81.40 284 -80.61 n/a n/a n/a
2019-02-14 2018-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 17,200 1,465 n/a n/a n/a
2018-08-14 2018-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-05-15 2018-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 50,000 0.00 4,054 -9.08 n/a n/a n/a
2018-02-14 2017-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 50,000 4,459 n/a n/a n/a
2015-08-18 2015-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2015-05-18 2015-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 35,000 108.33 4,362 269.04 n/a n/a n/a
2014-02-18 2013-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 16,800 1,182 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.